Standigm inks $10m

Seoul, South Korea-based Standigm Inc, a workflow artificial intelligence drug discovery company, has secured a $10 million investment from Pavilion Capital.

Seoul, South Korea-based Standigm Inc, a workflow artificial intelligence drug discovery company, has secured a $10 million investment from Pavilion Capital. The capital infusion will be used for clinical research.

Source: Press Release